Lv5
1051 积分 2021-08-16 加入
Clinical activity and safety of rilzabrutinib in patients with previously treated immune thrombocytopenia (LUNA3): results from the open-label period of a phase 3 trial
4天前
已完结
Vaccination considerations in autoimmune rheumatic diseases
9天前
已完结
A bispecific CD3×CD19 antibody for systemic lupus erythematosus: a phase 1 trial
10天前
已完结
Rheumatoid Arthritis in Adults
11天前
已完结
Rheumatoid Arthritis in Adults
12天前
已关闭
Varicella zoster virus infection
12天前
已完结
Delphi Consensus Statement on Treatment of Severe Alopecia Areata in US Adults
16天前
已完结
Roads and detours for CAR T cell therapy in autoimmune diseases
18天前
已完结
52‐week ivarmacitinib in moderate‐to‐severe atopic dermatitis: A phase 3 trial
18天前
已完结
CD19 CAR T cell therapy for treatment-refractory seropositive rheumatoid arthritis: a phase 1 trial
24天前
已完结
皖公网安备34019202002308
